<?xml version="1.0" encoding="UTF-8"?>
<p id="par0100">The data presented in 
 <xref rid="fig0010" ref-type="fig">Fig. 2</xref>a indicate that there were significant increases (
 <italic>P &lt; 0.05</italic>) in final mean body weights of test animals administered AESG 500, 1000, and 2000 mg/kg, respectively; including the control after 30 days, when compared with their respective initial mean body weights, taken before commencement of AESG administration. 
 <xref rid="fig0010" ref-type="fig">Fig. 2</xref>b clearly shows percentage (%) weight gain; indicates that rats administered respective doses of AESG gained significant weight (
 <italic>P &lt; 0.05</italic>) when compared to the control; in fact, rats administered AESG 500 and 2000 mg/kg, respectively, gained the highest weight. There were no significant differences in liver, kidney, and heart IOW/body weight ratios of test rats relative to the respective controls (
 <xref rid="fig0015" ref-type="fig">Fig. 3</xref>).
</p>
